These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 17229559)
1. [Management of childhood idiopathic thrombocytopenic purpura: a survey of members of the French Society of Pediatric Hematology and Immunology (SHIP)]. Lutz P; Villega F; Ducassou S; Entz-Werle N; Michel G; Arch Pediatr; 2007 May; 14(5):444-9. PubMed ID: 17229559 [TBL] [Abstract][Full Text] [Related]
2. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey. Marks MK; Vadamalayan B; Ekert H; South MJ J Paediatr Child Health; 2005; 41(1-2):52-5. PubMed ID: 15670225 [TBL] [Abstract][Full Text] [Related]
3. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. Vesely SK; Buchanan GR; Adix L; George JN; Cohen AR; Blanchette VS; Kühne T; J Pediatr Hematol Oncol; 2003 Feb; 25(2):130-3. PubMed ID: 12571464 [TBL] [Abstract][Full Text] [Related]
4. Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience. Del Vecchio GC; De Santis A; Giordano P; Amendola G; Baronci C; Del Principe D; Nobili B; Jankovic M; Ramenghi U; Russo G; Zecca M; De Mattia D; Acta Haematol; 2008; 119(1):1-7. PubMed ID: 18176072 [TBL] [Abstract][Full Text] [Related]
5. [Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)]. Blouin P; Auvrignon A; Pagnier A; Thuret I; Antoni G; Bader-Meunier B; Le Deist F; Chastagner P; Aladjidi N; Pellier I; Bertrand Y; Behar C; Landmann-Parker J; Leverger G; Perel Y Arch Pediatr; 2005 Nov; 12(11):1600-7. PubMed ID: 16185853 [TBL] [Abstract][Full Text] [Related]
6. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis. Buchanan GR; Journeycake JM; Adix L Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176 [TBL] [Abstract][Full Text] [Related]
7. Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician management. Neunert CE; Bright BC; Buchanan GR Pediatr Blood Cancer; 2008 Oct; 51(4):513-6. PubMed ID: 18506754 [TBL] [Abstract][Full Text] [Related]
8. A nationwide survey of newly diagnosed childhood idiopathic thrombocytopenic purpura in Japan. Shirahata A; Fujisawa K; Ishii E; Ohta S; Sako M; Takahashi Y; Taki M; Mimaya J; Kubota M; Miura T; Kitazawa J; Kajiwara M; Bessho F J Pediatr Hematol Oncol; 2009 Jan; 31(1):27-32. PubMed ID: 19125083 [TBL] [Abstract][Full Text] [Related]
9. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. Vesely S; Buchanan GR; Cohen A; Raskob G; George J J Pediatr Hematol Oncol; 2000; 22(1):55-61. PubMed ID: 10695823 [TBL] [Abstract][Full Text] [Related]
10. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia. Roganovic J; Letica-Crepulja M Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):662-4. PubMed ID: 16933251 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in the treatment of childhood immune thrombocytopenic purpura. Tarantino M Semin Hematol; 2006 Jul; 43(3 Suppl 5):S11-7; discussion S18-9. PubMed ID: 16815345 [TBL] [Abstract][Full Text] [Related]
13. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Lu KH; George JN; Vesely SK; Terrell DR Am J Med Sci; 2014 Mar; 347(3):190-4. PubMed ID: 23462246 [TBL] [Abstract][Full Text] [Related]
15. [Infant bronchiolitis point of care by physicians in the Ile-de-France bronchiolitis network]. Sebban S; Grimprel E; Bray J Arch Pediatr; 2007 May; 14(5):421-6. PubMed ID: 17391946 [TBL] [Abstract][Full Text] [Related]
16. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP]. Le Meignen M; Mossler P; Mates M; Mathey C; Hass A; Monpoux F; Faverge B; Fortier G; Nguyen J; Belahbib L; Coache C; Chamoulli JM; Moulène E; Sirvent N; Michel G; Chambost H Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127 [TBL] [Abstract][Full Text] [Related]
17. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)]. Kvezereli-Kopadze MA; Kvezereli-Kopadze AN; Mtvarelidze ZG Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732 [TBL] [Abstract][Full Text] [Related]
18. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related]
19. Controversies in the management of acute idiopathic thrombocytopenic purpura: a survey of specialists. Dubansky AS; Oski FA Pediatrics; 1986 Jan; 77(1):49-52. PubMed ID: 3940360 [TBL] [Abstract][Full Text] [Related]
20. Initial management of children with newly diagnosed idiopathic thrombocytopenic purpura in the Nordic countries. Treutiger I; Rajantie J; Zeller B; Elinder G; Rosthöj S; NOPHO ITP Working Group Acta Paediatr; 2006 Jun; 95(6):726-31. PubMed ID: 16754555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]